Cargando…
Deep brain stimulation for dystonia
Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory movement disorders, and has been approved by the United States Food and Drug Administration for treatment of dystonia. The success of DBS in the treatment of dystonia depends on our understanding of the anatomy...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902434/ https://www.ncbi.nlm.nih.gov/pubmed/24444300 http://dx.doi.org/10.1186/2047-9158-3-2 |
_version_ | 1782300983866425344 |
---|---|
author | Hu, Wei Stead, Matt |
author_facet | Hu, Wei Stead, Matt |
author_sort | Hu, Wei |
collection | PubMed |
description | Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory movement disorders, and has been approved by the United States Food and Drug Administration for treatment of dystonia. The success of DBS in the treatment of dystonia depends on our understanding of the anatomy and physiology of this disorder and close collaboration between neurosurgeons, neurologists, clinical neurophysiologists, neuroradiologists and neuropsychologists. Currently, pallidal DBS is an established treatment option for medically refractive dystonia. This review is intended to provide a comprehensive review of the use of DBS for dystonia, focusing mainly on the surgical aspects, clinical outcome, MRI findings and side effects of DBS. |
format | Online Article Text |
id | pubmed-3902434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39024342014-01-28 Deep brain stimulation for dystonia Hu, Wei Stead, Matt Transl Neurodegener Review Deep brain stimulation (DBS) is an effective surgical treatment for medication-refractory movement disorders, and has been approved by the United States Food and Drug Administration for treatment of dystonia. The success of DBS in the treatment of dystonia depends on our understanding of the anatomy and physiology of this disorder and close collaboration between neurosurgeons, neurologists, clinical neurophysiologists, neuroradiologists and neuropsychologists. Currently, pallidal DBS is an established treatment option for medically refractive dystonia. This review is intended to provide a comprehensive review of the use of DBS for dystonia, focusing mainly on the surgical aspects, clinical outcome, MRI findings and side effects of DBS. BioMed Central 2014-01-21 /pmc/articles/PMC3902434/ /pubmed/24444300 http://dx.doi.org/10.1186/2047-9158-3-2 Text en Copyright © 2014 Hu and Stead; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Hu, Wei Stead, Matt Deep brain stimulation for dystonia |
title | Deep brain stimulation for dystonia |
title_full | Deep brain stimulation for dystonia |
title_fullStr | Deep brain stimulation for dystonia |
title_full_unstemmed | Deep brain stimulation for dystonia |
title_short | Deep brain stimulation for dystonia |
title_sort | deep brain stimulation for dystonia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902434/ https://www.ncbi.nlm.nih.gov/pubmed/24444300 http://dx.doi.org/10.1186/2047-9158-3-2 |
work_keys_str_mv | AT huwei deepbrainstimulationfordystonia AT steadmatt deepbrainstimulationfordystonia |